Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

NCT05910099 | Not Yet Recruiting

• 1 other identifier: 85996123
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective of this research study is to explore the barriers encountered by specific demographic groups of rectal cancer patients during the engagement in clinical trials, which historically lack diverse representation. By carefully analyzing data from various demographic perspectives, this study aims to uncover patterns that impact the experiences of future rectal cancer patients. Active involvement in this crucial research is of utmost importance, as it can offer unique insights to enhance the participation and completion rates of rectal cancer patients in clinical study.

Conditions

Rectal Cancer

Keywords

Rectal Cancer

Outcome Measures

Primary Outcomes (2)

• Number of rectal cancer patients who decide to participate in a clinical study

  3 months

• Rate of patients who remain in a rectal cancer clinical study to completion

  12 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with rectal cancer who are actively participating in a clinical research, but have not yet completed enrollment and randomization.

You may qualify if:

• Confirmed diagnosis of rectal cancer
• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• No prior treatment for rectal cancer

You may not qualify if:

• Pregnant or lactating woman
• Inability to provide written informed consent
• Enrolled in another research study

Sponsors & Collaborators

• Power Life Sciences Inc.: lead

Study Sites (1)

Power Life Sciences

San Francisco, California, 94107, United States

Location

Related Publications (3)

• Alvarez Sarrado E, Giner Segura F, Batista Domenech A, Garcia-Granero Garcia-Fuster A, Frasson M, Rudenko P, Flor Lorente B, Garcia-Granero Ximenez E. Rectal cancer at the peritoneal reflection. Preoperative MRI accuracy and histophatologic correlation. Prospective study. Cir Esp (Engl Ed). 2022 Aug;100(8):488-495. doi: 10.1016/j.cireng.2022.05.019. Epub 2022 May 18.

  PMID: 35597413 BACKGROUND

• Bregendahl S, Bondeven P, Gronborg TK, Brown G, Laurberg S, Pedersen BG. Training of radiology specialists in local staging of primary rectal cancer on MRI: a prospective intervention study exploring the impact of various educational elements on the interpretive performance. BMJ Open Qual. 2022 Aug;11(3):e001716. doi: 10.1136/bmjoq-2021-001716.

  PMID: 35944932 BACKGROUND

• Qaderi SM, Dickman PW, de Wilt JHW, Verhoeven RHA. Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study. J Natl Compr Canc Netw. 2020 Sep;18(9):1230-1237. doi: 10.6004/jnccn.2020.7568.

  PMID: 32886900 BACKGROUND

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal Neoplasms; Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases

Study Officials

• Michael B Gill

  Power Life Sciences Inc.

  STUDY DIRECTOR

Central Study Contacts

Michael B Gill

CONTACT

4159004227; bask@withpower.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 9, 2023
• First Posted: June 18, 2023
• Study Start: July 1, 2024
• Primary Completion: July 1, 2025
• Study Completion (Estimated): July 1, 2026
• Last Updated: June 18, 2023

Record last verified: 2023-06

Locations

US (1)